PTCY-BASED HAPLOIDENTICAL TRANSPLANTATION, WITH REDUCED-DOSE MMF, 30 MG/KG, AND A CALCINEURIN INHIBITOR, COMPARED WITH ATG-BASED, 6 MG/KG, UNRELATED DONOR TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES LJ Arcuri; CO Ribeiro; IO Fernandes-Junior; SC Maradei; SP Lermontov; D Lerner;

AVALIAÇÃO ODONTOLÓGICA ANTES DO TRANSPLANTE DE CÉLULAS-TRONCO HEMATOPOIÉTICAS NO INSTITUTO NACIONAL DE CÂNCER LDB Alves; SP Lermontov; JKP Queiroz; JSR Pereira; ACDS Menezes; SCM Pereira; MCR Moreira; D Lerner; HS Antunes;

MATCHED-SIBLING, MATCHED-UNRELATED, OR HAPLOIDENTICAL TRANSPLANTATION FOR ACUTE LEUKEMIAS AND MYELODYSPLASIA IN BRAZIL: A PROSPECTIVE MULTICENTER STUDY IN COLLABORATION WITH THE CIBMTR LJ Arcuri; MN Kerbauy; VAR Colturato; P Scheinberg; GMN Barros; MCMA Macedo; VAM Funke; VG Zecchin; M Pasquini; N Hamerschlak;